The intraerythrocytic stage of the human malaria parasite Plasmodium falciparum relies on glycolysis for ATP generation, and because it has no energy stores, a constant supply of glucose is necessary for the parasite to grow and multiply. The 2-substituted glucose analogs 2-deoxy-D-glucose (2-DG) and 2-fluoro-2-deoxy-D-glucose (2-FG) have been previously shown to inhibit the in vitro growth of P. falciparum and have been suggested to do so by inhibiting glycosylation in the parasite. In this study, we have investigated the antiplasmodial mechanism of action of 2-DG and 2-FG and compared it with that of other 2-substituted-glucose analogs. The compounds tested inhibited parasite growth to varying degrees, with 2-FG being the most effective. The antiplasmodial activity of some, but not all, of the analogs could be altered by varying the glucose concentration in the culture medium, increasing the antiplasmodial activity of the analogs as the glucose concentration is reduced. A trend was observed between the antiplasmodial activity of these analogs and their ability to inhibit glucose accumulation, glucose phosphorylation by hexokinase, and cytosolic pH regulation within the intraerythrocytic stage of the parasite. Our data are consistent with inhibition of glycolysis being a primary mechanism by which 2-DG and 2-FG inhibit parasite growth, and they validate the early steps in glycolysis as viable drug targets.
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The human malaria parasite Plasmodium falciparum relies heavily on glycolysis for the generation of ATP and has no energy stores (e.g., glycogen) (Sherman, 1998) . The rate of glycolysis in P. falciparum-infected erythrocytes is significant, generating lactate at 20 to 100 times the rate observed in uninfected cells (Pfaller et al., 1982; Vander Jagt et al., 1990) . A constant supply of glucose is critical for the survival of the parasite because removal of glucose from the extracellular solution results in rapid (within a few minutes) depletion of ATP levels within the parasite cytosol (Kirk et al., 1996; Saliba and Kirk, 1999) .
A number of studies have investigated glucose analogs as potential inhibitors of glucose transport into the parasite (Joet et al., 2002 (Joet et al., , 2003 (Joet et al., , 2004 Ionita et al., 2007) . Glucose transport across the parasite plasma membrane is mediated by PfHT (Plasmodium falciparum hexose transporter), a saturable and equilibrative transporter located on the plasma membrane of parasites (Woodrow et al., 1999) . One of the most promising glucose analogs identified in these studies is compound 3361 [3-O-((undec-10-en) -yl)-D-glucose]. Compound 3361 was shown to be a selective inhibitor of PfHT (compared with other glucose transporters) and an effective inhibitor of the growth of Plasmodium parasites, both in vitro and in vivo (Joet et al., 2003 (Joet et al., , 2004 , validating glucose transport into the malaria parasite as a viable drug target.
Compound 3361 has been shown to have no effect on glucose phosphorylation by the malaria parasite's hexokinase (the first enzyme involved in glycolysis) (Saliba et al., 2004) . Whereas this observation confirms the specificity of this compound for PfHT, it leaves open the possibility that inhibition of glycolysis may serve as another potential drug target. A recent study investigating the effect of 2-substituted D-glucose analogs on "hypoxic tumor cells" found that their growth inhibitory activity was related to their affinity for hexokinase and their ability to inhibit glycolysis (Lampidis et al., 2006) . Two of the analogs tested, 2-deoxy-D-glucose (2-DG) and 2-fluoro-2-deoxy-D-glucose (2-FG), had been previously shown to inhibit malaria parasite growth, and their activity was attributed to their ability to inhibit glycosylation in the parasite (Udeinya and Van Dyke, 1981; Dieckmann-Schuppert et al., 1992; Santos de Macedo et al., 2001) .
In this study, we have investigated the mechanism by which a series of 2-substituted glucose analogs inhibit parasite proliferation. We show that two of the compounds do so by competition with glucose and that they inhibit glucose accumulation into "isolated" parasites, doing so primarily by inhibiting the phosphorylation of glucose by hexokinase. Addition of the compounds to the parasites results, to varying degrees, in the rapid acidification of the parasite cytosol, inhibition of glucose phosphorylation by hexokinase, and a marked reduction in the ATP levels within the parasite. We propose that these effects will contribute to antiplasmodial activity of these compounds.
Materials and Methods
Materials. Chloroquine (CQ) diphosphate, adenosine triphosphate, firefly lantern extract, 2-DG, and D-glucose were purchased from Sigma-Aldrich (St. Louis, MO). [
14 C]2-DG was purchased from PerkinElmer Life and Analytical Sciences (Waltham, MA). [
3 H]Hypoxanthine was purchased from GE Healthcare (Little Chalfont, Buckinghamshire, UK). Albumax II, gentamicin sulfate, HEPES, SYBR Green, and the acetoxymethyl ester form of the pH indicator BCECF were purchased from Invitrogen (Carlsbad, CA). All of the halogenated 2-deoxy-D-glucose analogs were synthesized using previously described procedures (Lampidis et al., 2006) . Parasite Culture. Experiments were performed on either the chloroquine-sensitive (CQS) 3D7 or chloroquine-resistant (CQR) K1 strain of P. falciparum. The parasites were maintained in O ϩ human erythrocytes suspended in RPMI 1640 culture medium as described previously (Allen and . The culture medium was supplemented with 25 mM sodium bicarbonate, 24 g/ml gentamicin sulfate, 11 mM glucose, 25 mM HEPES, 200 M hypoxanthine, and 6 g/l Albumax II. The parasites were kept in continuous culture at 37°C under a gas mixture of 3% CO 2 , 1% O 2 , and 96% N 2 . Cultures were synchronized in the ring stage with 10 volumes of 5% (w/v) D-sorbitol (Lambros and Vanderberg, 1979) .
Parasite Proliferation Assay. Parasite proliferation was measured using either the [ 3 H]hypoxanthine incorporation assay (Desjardins et al., 1979) or, in the case of the isobologram analysis (see below), the SYBR Green assay (Bennett et al., 2004; Smilkstein et al., 2004) . All of the experiments were initiated with the parasites in the trophozoite stage and the parasitemia set to 2% and the hematocrit set to 1%. Parasites were incubated for 48 h in the presence of the test compounds and either 5 or 20 mM glucose.
[ 14 C]2-Deoxy-D-glucose Uptake Measurements. The uptake of [ 14 C]2-DG into saponin-permeabilized trophozoite-infected erythrocytes was performed essentially as described previously (Saliba et al., 1998) . In brief, the parasites were isolated from the red blood cells by suspension in 50 ml of RPMI medium containing 0.05% (w/v) saponin for Յ30 s. They were then centrifuged at 2000g for 8 min, and the supernatant was removed. The isolated trophozoites were then washed four times in saline containing 125 mM NaCl, 5 mM KCl, 20 mM glucose, 25 mM HEPES, and 1 mM MgCl 2 , pH 7.1. The parasites were then suspended in saline (0.8 -2 ϫ 10 8 cells/ml) and incubated at 37°C until the experiment was performed (generally less than 30 min). At the start of the experiment, the parasites were suspended in 2 ml of saline containing a reduced glucose concentration (0.2 mM), [
14 C]2-DG (0.1 Ci/ml; 2 M), and one of the 2-deoxy-D-glucose analogs (2 mM). An inhibitor-free control and a control containing 2 mM D-glucose (instead of one of the analogs) were also included. At predetermined time points, 200-l aliquots of the cell suspension (0.4 -1 ϫ 10 8 cells/ml) were layered on an oil mixture (a 5:4 mix of dibutyl phthalate/dioctyl phthalate) and centrifuged (16000g, 30 s) to separate the parasites from the extracellular solution (which contained the [ 14 C]2-DG not taken up by the parasite). The supernatant (composed of the oil mixture and the extracellular solution) was then removed, and the pellet was processed as described previously (Saliba et al., 1998) . The amount of radioactivity in the pellet was measured in a scintillation counter. The uptake is reported as "Distribution Ratios", which represent the ratio of the intracellular concentration of the radiolabel relative to the extracellular concentration. A parasite volume of 28 fL was assumed in these calculations (Saliba et al., 1998) .
Phosphorylation of [ 14 C]2-Deoxy-D-glucose by Parasite Lysates. Parasite hexokinase activity was measured using lysates prepared from saponin-isolated trophozoite-stage parasites as described elsewhere (Saliba et al., 1998) . In brief, the parasites were diluted 1/10 in a 10 mM Tris buffer (pH 7.4) and triturated 10 times through a 25-gauge needle. The lysate was then clarified by three centrifugation steps at 2000g for 30 min. At the end of each centrifugation step, the supernatant was transferred to a new tube. The lysates were stored at Ϫ20°C, and aliquots were thawed when required.
The assay was performed in 50-l volumes in a 96-well microtiter plate as described recently for pantothenate kinase (Lehane et al., 2007) . The phosphorylation reaction was commenced by adding the lysate (125 l/ml) to a solution containing 50 mM Tris, 5 mM ATP, 5 mM MgCl 2 , and 0.1 Ci/ml Measurements of ATP Levels in the Parasite Cytosol. The parasite ATP concentration was measured using firefly luciferase as described previously (Saliba and Kirk, 1999) , with modifications. The experiment was performed in 50-l aliquots in a 96-well microtiter plate. Saponin-isolated parasites were suspended (final cell density, 3-4 ϫ 10 7 /ml) in saline containing 0.5 mM glucose in the absence or presence of the 2-deoxy-D-glucose analogs (2 mM) or Dglucose (2 mM). At selected time points, the ATP synthesis/utilization was terminated by adding 100 l of HCl (0.1 M). Thereafter, 75 l of the solution was removed and diluted in 200 l of water. From the resulting solution, a 15-l aliquot was placed into a white (to eliminate any cross-talk between wells) 96-well plate. A buffered solution (185 l) composed of 20 mM HEPES, 25 mM MgCl 2 , 5 mM Na 2 HPO 4 , and firefly lantern extract (1% v/v), pH 7.4, was added. The luminescence was measured immediately in a FLUOstar Optima microplate reader (BMG Labtech, Durham, NC). An ATP calibration curve (0.04 -4.5 M; which is linear over this range) was performed in each experiment and used to estimate the intracellular ATP concentration, again assuming a parasite volume of 28 fL (Saliba et al., 1998) .
pH Measurements in the Parasite Cytosol. The parasite cytosolic pH was measured using the pH-sensitive fluorescent dye, BCECF. Saponin-isolated trophozoite-stage parasites were loaded with the acetoxymethyl ester of BCECF as described elsewhere (Saliba and Kirk, 1999) . The parasites were then suspended in saline (cell density 2-5 ϫ 10 7 /ml) containing 0.5 mM glucose in the absence or presence of the 2-deoxy-D-glucose analogs (2 mM). D-Glucose (2 mM), instead of the 2-deoxy-D-glucose analogs, was also included as a control. The parasite samples were then loaded into a 96-well microtiter plate, and the change in fluorescence was recorded in a FLUOstar Optima microplate reader in a temperature-controlled chamber at 37°C. The fluorescence was measured at a wavelength of 520 nm after dual excitation at wavelengths of 440 and 490 nm. The ratio of the fluorescence measured at the dual wavelengths (490/440 nm) provides a qualitative measure of the pH. A pH calibration was performed in each experiment using nigericin (Saliba and Kirk, 1999) . The BCECF-loaded parasites were suspended in a high K ϩ saline (130 mM KCl, 25 mM HEPES, 20 mM glucose, and 1 mM MgCl 2 ) at a pH of 6.8, 7.3, and 7.8. Nigericin (15 M) was added to the solution, which induced a rapid equilibration of the intracellular and extracellular pH. The equation derived from the linear regression (r 2 ϭ 0.998 Ϯ 0.002; mean Ϯ S.E.M.; n ϭ 6) of the plot between the intracellular fluorescence ratios at the different pH values was used to convert the experimental fluorescence ratio into intracellular pH.
Isobolograms. To examine the in vitro interaction of 2-DG with either chloroquine or artemisinin, fixed-ratio isobolograms were constructed essentially as described by Fivelman et al. (2004) . All of the experiments were performed in RPMI medium containing a physiological glucose concentration (5 mM). Each assay was initiated in the trophozoite stage of growth, and the parasite viability was determined 48 h later. The individual IC 50 was first determined for each drug to be tested in combination. This IC 50 value was then used to determine the starting concentration for the combination studies such that when the compound was tested alone, the IC 50 appeared at the fourth serial dilution in the 96-well plate. Then, assuming that one drug in the combination to be tested is called "A" and the other is called "B", stock solutions were prepared containing ratios of A and B. Six combinations were used in the following ratios: 1.0A/0.0B; 0.8A/0.2B; 0.6A/0.4B; 0.4A/0.6B; 0.2A/0.8B; and 0.0A/1.0B. These combinations were then serially diluted (2-fold) a total of seven times, and the parasites were added to give a final hematocrit of 1%. The parasitemia was set at 2%.
In this series of experiments, parasite proliferation was measured using the SYBR Green dye, which fluoresces when intercalated with DNA (Bennett et al., 2004; Smilkstein et al., 2004) . After the 48-h incubation in the drug combinations, the parasites were resuspended in the incubation medium, and 100 l was transferred into a new 96-well plate. Lysis buffer (100 l) containing the SYBR Green (0.02% v/v) was added to each well. The lysis buffer contained 20 mM Tris, 5 mM EDTA, 0.008% (w/v) saponin, and 0.08% (v/v) Triton X-100, pH 7.5. The fluorescence emitted was measured at 520 nm after excitation at 490 nm. The fractional inhibitory concentrations (FICs) were calculated for each drug in a particular combination as follows: FIC (A) ϭ IC 50 for A in a combination/IC 50 for A alone; FIC (B) ϭ IC 50 for B in the combination/IC 50 for B alone. The isobolograms were constructed by plotting FIC (A) versus FIC (B) for each combination. It is generally accepted that a drug combination is synergistic if the FIC values are lower than 0.5 and antagonistic if they are greater than 2 (Bell, 2005) or perhaps even 4 (Odds, 2003; Johnson et al., 2004) . The nature of the interaction between drugs with an FIC of between 0.5 and 2 (or 4) should be considered indifferent (Odds, 2003) .
Statistics and Analysis of Rates. The p values were determined using a Student's two-tailed t test for paired or unpaired samples, as appropriate. The rates of [ 14 C]2-DG phosphorylation were obtained by fitting the data to the first-order equation y ϭ a ϫ (1 Ϫ e Ϫkt ), where a is the maximal amount of [ 14 C]2-DG phosphorylated and k is the first-order rate constant. The product of a and k (obtained from the fitted curves shown in Fig. 3 ) yields the initial rate of [ 14 C]2-DG phosphorylation. The initial uptake rates of [ 14 C]2-DG were obtained in the same way (but using the data shown in Fig. 2) .
Results
Antiplasmodial Activity of the 2-Deoxy-D-Glucose Analogs. In the presence of 20 mM glucose (the standard glucose concentration routinely used for the in vitro culture of P. falciparum), all of the 2-deoxy-D-glucose analogs (see Fig. 1 for structures) inhibited parasite proliferation with IC 50 values in the range of 1.6 to 6.2 mM against the CQS strain (3D7; CQ IC 50 ϭ 14 Ϯ 1 nM), with 2-FG being the most active (p Յ 0.047). When tested against a CQR strain (K1; CQ IC 50 ϭ 331 Ϯ 37 nM) at the same glucose concentration (20 mM), the IC 50 values for 2-DG, 2-FG, and 2-bromo-2-deoxy-D-glucose (2-BG) were not significantly different from those observed against 3D7 (p Ն 0.11), whereas the IC 50 value of 2-chloro-2-deoxy-D-glucose (2-CG) was significantly higher (ϳ3 fold; p ϭ 0.004) ( Table 1) . It is important to note that in the presence of a physiological concentration of glucose (5 mM), the IC 50 values of 2-DG and 2-FG obtained against both K1 and 3D7 were 5 to 6-fold lower (p Յ 0.01) ( Table 1) compared with those obtained in the presence of 20 mM glucose, consistent with these two analogs inhibiting parasite proliferation by inhibiting glucose utilization (transport and/or metabolism) by the parasite. The lower glucose concentration (5 mM) had no effect on the 2-BG IC 50 against both strains (p Ն 0.65). Likewise, the lower glucose concentration had no effect on the 2-CG IC 50 against 3D7 (p ϭ 0.8), but it significantly lowered the 2-CG IC 50 against the K1 strain (2-fold; p ϭ 0.01). Varying the glucose concentration had no effect on the chloroquine IC 50 values (p Ն 0.76).
Effect of the Analogs on [ 14 C]2-Deoxy-D-Glucose Uptake into Isolated Parasites. All of the analogs were tested at 2 mM for their ability to inhibit the uptake (a combination of transport and metabolism) of [ 14 C]2-DG into saponin-isolated parasites. The reason we used [
14 C]2-DG (instead of radioactive glucose) is because it is known that 2-DG is transported into the parasite and is phosphorylated by hexokinase, but it does not progress further down the glycolysis pathway (Kirk et al., 1996) . Therefore, it is possible to examine the effect of the inhibitors on transport (by PfHT) and phosphorylation (by hexokinase) in isolation of any additional effect on glycolysis. In the absence of any inhibitors, [ 14 C]2-DG is taken up into the parasite to a distribution ratio of Ͼ20 within the 5-min time course (Fig. 2) , consistent with its transport and metabolism into the parasite as reported previously (Kirk et al., 1996; Krishna et al., 2000; Saliba et al., 2004) . Glucose (included as a positive control), 2-DG, and 2-FG almost completely inhibit the uptake of [ 14 C]-2-DG, keeping the distribution ratio to Յ1. On the other hand, 2-CG and 2-BG were less effective inhibitors of [ 14 C]2-DG uptake, reducing the initial rate of uptake by 69 Ϯ 8 and 52 Ϯ 4%, respectively.
Effect of the Analogs on the Phosphorylation of [ 14 C]2-DG by Parasite Lysates. The inhibition of [
14 C]2-DG uptake into isolated parasites by the 2-deoxy-D-glucose analogs (Fig. 2) could be a result of inhibition of [ 14 C]2-DG transport by PfHT or [ 14 C]2-DG phosphorylation by hexokinase. Because 2-DG does not progress into glycolysis further than hexokinase (Kirk et al., 1996) , we were able to test the effect of the 2-deoxy-D-glucose analogs on [ 14 C]2-DG phos- jpet.aspetjournals.org phorylation by parasite lysates directly. Glucose was included as a control, and, as expected, it was an effective inhibitor of [ 14 C]2-DG phosphorylation, reducing the initial rate by 96 Ϯ 1% (Fig. 3) . The 2-deoxy-D-glucose analogs (at 2 mM) inhibited the phosphorylation of [ 14 C]2-DG to varying degrees, with 2-FG being the most effective inhibitor, reducing the rate of [ 14 C]2-DG phosphorylation by 94 Ϯ 1% (p Յ 0.02). 2-DG, 2-CG, and 2-BG reduced the rate of [ 14 C]2-DG phosphorylation by 86 Ϯ 1, 67 Ϯ 4, and 37 Ϯ 4%, respectively (Fig. 3) . This suggests that, at least in part, these analogs exert their antiplasmodial effect by inhibiting glucose phosphorylation by the parasite hexokinase.
Effect of the Analogs on the ATP Levels of Isolated Trophozoites. Given the fact that the parasite is dependent, to a great extent, on glycolysis for its energy requirements, inhibition of glucose phosphorylation by the 2-deoxy-D-glucose analogs (Fig. 3) would be expected to result in a decrease in the ATP levels in the parasite. This theory was tested directly. Saponin-isolated parasites were suspended in saline containing 0.5 mM glucose, to which 2 mM of the analogs or an additional 2 mM glucose (as a control) was added. The ATP levels were then measured over time using the luciferin/ luciferase assay. Figure 4 shows that in the presence of 0.5 or 2.5 mM glucose, the ATP levels within the parasite were maintained at ϳ3 mM over a period of 4 min. Addition of 2-FG and 2-DG (in the presence of 0.5 mM glucose) induced a rapid decrease in the ATP levels in the parasites over time, resulting in a ϳ3-fold decrease within 2 min (Fig. 4) . 2-CG induced what seems to be a small decrease in the ATP level, although this did not reach statistical significance under the conditions tested (p ϭ 0.065). Under the same conditions, 2-BG was without an effect on the ATP concentration (Fig. 4) .
Effect of the Analogs on the Cytosolic pH of Isolated Trophozoites.
A reduced ATP concentration in the parasite has been previously shown to result in a decrease in the parasite cytosolic pH (Saliba and Kirk, 1999) . This occurs because the parasite relies mainly on a plasma membranebound, ATP utilizing V-type H ϩ -pump to regulate its cytosolic pH (Saliba and Kirk, 1999) . To test whether the 2-deoxy-D-glucose analogs induce a similar effect, saponin-isolated trophozoites loaded with a pH-sensitive fluorophore, BCECF, were suspended in saline containing 0.5 mM glucose, and the fluorescence was monitored over time. In each instance, addition of 2 mM of each of the 2-deoxy-D-glucose analogs to the parasites led to an acidification of the parasite cytosol (Fig.  5) . Once again, the most active of the analogs were 2-FG and 2-DG, both of which induced a rapid acidification to a pH value of approximately 6.9. Both 2-CG and 2-BG induced a more gradual decrease in the cytosolic pH that did not reach the same levels as those observed with the other analogs tested within the time period of the experiment. In this assay, 2-BG again appeared to be the least active of the analogs. Over time, the control parasites also experienced a decrease in the cytosolic pH, presumably as they began to exhaust their glucose supply. This is supported by the demonstration that the cytosol of the parasites supplied with additional glucose (2.5 mM final glucose concentration) did not acidify throughout the time course of the experiment (Fig. 5) .
Isobologram Analysis of the Interaction of 2-Deoxy-D-Glucose with Either Chloroquine or Artemisinin. In a preliminary analysis of the in vitro interaction between the 2-deoxy-D-glucose analogs and conventional antimalarial drugs, 2-DG was combined with either CQ or artemisinin in fixed-ratio combinations using methods described previously (Fivelman et al., 2004) , and their interaction was examined using isobole analysis (Fig. 6 ). The interactions of 2-DG with either CQ or artemisinin yielded FIC values within a range of 1 to 1.3. No strain-specific interaction was observed between 2-DG and either CQ or artemisinin (Fig. 6) . Although there is a lack of synergy in any of the combinations, and the curves tend toward an antagonistic effect (i.e., an FIC Ͼ1), all FIC values remain well within the cut-off for antagonism of 2 to 4 (Greco et al., 1995; Odds, 2003; Johnson et al., 2004) . Therefore, we interpret these in vitro interactions between 2-DG and two conventional antimalarial drugs as indifferent.
Discussion
There is no question that the intraerythrocytic stage of the human malaria parasite P. falciparum relies heavily on a constant supply of extracellular glucose to survive (Roth, 1987; Sherman, 1998; Saliba et al., 2003) . A number of glucose analogs, including 2-DG and 2-FG, have been previously reported to possess antiplasmodial activity (Udeinya and Van Dyke, 1981; Dieckmann-Schuppert et al., 1992; Santos de Macedo et al., 2001 ). In addition to confirming and extending the description of the antiplasmodial activity of 2-DG and 2-FG (Table 1) , we also report for the first time the antiplasmodial activity of 2-CG and 2-BG. The previous reports (Udeinya and Van Dyke, 1981; Dieckmann-Schuppert et al., 1992; Santos de Macedo et al., 2001) linked the antiplasmodial activity of 2-DG and 2-FG to inhibition of parasite glycosylation. In this study, we demonstrate that these two glucose analogs inhibit glucose ([ 14 C]2-DG) accumulation, doing so at least partly by inhibiting its phosphorylation by hexokinase. We also show that this results in a rapid decrease in cytosolic ATP levels, which consequently causes the parasite cytosolic pH to decrease.
Inhibition of Glucose Accumulation. The reduction of the ATP concentration within the parasites (Fig. 4) induced by 2-FG and 2-DG is consistent with these analogs inhibiting glycolysis and/or glucose transport into the parasites. It has been previously reported that glucose equilibrates across the parasite plasma membrane very rapidly [in less than 20 s (Kirk et al., 1996) ]. The resolution of the time scale of the [ 14 C]2-DG uptake experiment (Fig. 2) does not allow us to establish whether 2-FG and 2-DG inhibited [
14 C]2-DG transport during the course of the experiment, but the fact that it reached a distribution ratio of approximately 0.4 and 0.8 in the presence of 2-FG and 2-DG, respectively, within the first 14 C]2-DG phosphorylation by hexokinase. This was directly demonstrated to be the case by monitoring parasite hexokinase activity in parasite lysates (Fig. 3) .
However, the exact mechanism for the reduced [ 14 C]2-DG phosphorylation rates observed by parasite lysates in the presence of the 2-deoxy-D-glucose analogs (Fig. 3) is unclear. It may be either a result of inhibition of hexokinase (i.e., preventing the enzyme from working) or the analogs may be substrates for hexokinase (i.e., the analogs become phosphorylated by hexokinase). Because 2-DG is known to be phosphorylated by the parasite hexokinase (Kirk et al., 1996) , the latter scenario is likely to be the case for this glucose analog, but whether the same situation applies to the other inhibitors remains to be established. The fact that 2-FG is known to be phosphorylated by hexokinases in other systems (Nakada et al., 1986; Southworth et al., 2003) suggests that 2-FG might also act as a substrate for the parasite hexokinase.
Loss of pH Regulation. The parasite maintains a cytosolic pH (ϳ7.3) (Saliba and Kirk, 1999; Hayashi et al., 2000) that is alkaline relative to the infected erythrocyte cytosol (pH ϳ7.1) (Wunsch et al., 1997) . The pH is mainly regulated by an ATP utilizing V-type H ϩ -pump (Saliba and Kirk, 1999) . Inactivation of this pump by either specific inhibitors (e.g., bafilomycin A 1 ) (Saliba and Kirk, 1999; Saliba et al., 2003) or reducing the parasite's energy source (ATP) by glucose depletion or inhibition of glucose transport has been shown to result in the rapid acidification of the parasite cytosol (Saliba and Kirk, 1999; Saliba et al., 2004) and alkalinization of the parasite digestive vacuole (Saliba et al., 2003) . The parasite digestive vacuole is involved in an important process for the parasite, the digestion of the host cell hemoglobin by pH-sensitive proteases (Rosenthal, 2002) . Like the pH of the parasite cytosol, the digestive vacuole pH is also regulated by an ATP utilizing V-type H ϩ -pump (Saliba et al., 2003) . Therefore, although not shown directly in this study, an alkalinization of the digestive vacuole is also likely to take place in the presence of the 2-deoxy-Dglucose analogs, and this would be expected to disrupt, among other things, hemoglobin digestion.
Antiplasmodial Mechanism of Action. The antiplasmodial activities of 2-DG and 2-FG have been previously attributed to the inhibitory effect observed by these compounds on glycosylation by the parasite (Udeinya and Van Dyke, 1981; Dieckmann-Schuppert et al., 1992; Santos de Macedo et al., 2001) , although additional effects, including inhibition of glycolysis, could not be ruled out (Udeinya and Van Dyke, 1981) . The observed decrease in ATP levels (Fig. 4) , the acidification of the parasite cytosol (Fig. 5) , and the likely alkalinization of the digestive vacuole upon addition of the 2-deoxy-D-glucose analogs would all be expected to contribute to the antiplasmodial mechanism of action of these compounds. The association between the antiplasmodial activity of the analogs and their ability to inhibit the uptake and phosphorylation of [ 14 C]2-DG, inhibit the synthesis of ATP, and disrupt the cytosolic pH in trophozoites (2-FG Ͼ 2-DG Ͼ 2-CG Ն 2-BG) is consistent with their primary mechanism of action being inhibition of glycolysis. These compounds have been previously tested against hypoxic tumor cells, and a similar trend in their activity was observed (Lampidis et al., 2006) .
It is not clear why (unlike the situation with 2-FG and 2-DG) the antiplasmodial activity of 2-CG and 2-BG was not altered when the glucose concentration in the growth medium was varied (Table 1) . One possibility is that the mechanism by which they cause parasite death is unrelated to an effect on glucose use. The moderate effects of 2-CG, and especially 2-BG, on ATP levels, [
14 C]2-DG uptake, and phosphorylation and cytosolic pH (Figs. 2, 3 , and 4) may indicate that their antiplasmodial activity operates via a different mechanism from that of 2-FG and 2-DG, although the possibility that concentrations greater than the antiplasmodial IC 50 values of 2-CG and 2-BG are required to exhibit a more pronounced effect cannot be excluded [we note that the concentration of the analogs used in these assays was between 4 Fig. 6 . Isobolograms showing the interaction between 2-deoxy-D-glucose and either artemisinin (A) or chloroquine (B) performed on the CQS strain (filled circles) or on the CQR strain (empty circles). Axes represent the mean fractional inhibitory concentration (FIC) for the compounds tested. The straight line represents a hypothetical additive interaction. FIC values need to be below 0.5 or above 2 -4 to represent synergism or antagonism, respectively (Greco et al., 1995; Odds, 2003; Johnson et al., 2004) . The data are averaged from 3 independent experiments each carried out in triplicate. Error bars represent S.E.M.
van Schalkwyk et al.
at ASPET Journals on August 3, 2017 jpet.aspetjournals.org and 1000-fold higher than that of glucose (or [ 14 C]2-DG)]. Another possibility is that these compounds act as irreversible and, therefore, essentially noncompetitive (with glucose) inhibitors of hexokinase and/or PfHT, but that over the time scale of the assays used (glucose uptake, determination of ATP levels, and cytosolic pH measurements), this does not become apparent. Further research is needed to distinguish between these possibilities.
Inhibitors of Glycolysis in Combination with Antimalarial Drugs. The emergence and spread of malaria parasites resistant to several of the available antimalarials has rendered many of these drugs useless. As a result, combination therapy (where two, but sometimes even three, antimalarial drugs are combined) is now often regarded as the best way to treat uncomplicated malaria (Kremsner and Krishna, 2004; Dorsey et al., 2007) . Therefore, potential drug combinations need to be investigated for undesired interactions. Assuming that 2-DG kills the parasite by inhibiting glycolysis, the indifferent in vitro interactions of 2-DG with either CQ or artemisinin (Fig. 6 ) suggest that agents directed at inhibiting glycolysis should not be precluded from potential combination therapies with conventional antimalarial drugs. Although a synergistic interaction would always be preferable, the lack of strong antagonism and the lack of strainspecific differences in the interaction are encouraging. This result would have to be confirmed in vivo and in more strains before any further conclusions could be drawn.
Concluding Remarks. In addition to previous reports on the antiplasmodial activity of 2-deoxy-D-glucose analogs (2-DG and 2-FG) via inhibition of parasite glycosylation (Udeinya and Van Dyke, 1981; Dieckmann-Schuppert et al., 1992; Santos de Macedo et al., 2001) , we demonstrate that these analogs also inhibit glycolysis. Although glucose analogs (such as the ones used in this study) may not necessarily be suitable lead compounds for the development of antimalarial drugs, our data provide evidence that inhibition of the early steps in glycolysis results in the rapid and lethal disruption of important processes in parasite physiology. Therefore, these steps may be regarded as viable drug targets.
